EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 -0.0046
March 31, 2026 -0.0016
September 30, 2025 0.00
June 30, 2025 -0.0085
March 31, 2025 -0.0038
October 31, 2024 0.00
July 31, 2024 0.00
April 30, 2024 0.00
January 31, 2024 -0.0002
October 31, 2023 -0.001
July 31, 2023 -0.0003
April 30, 2023 0.0578
January 31, 2023 -0.0003
October 31, 2022 -0.0012
July 31, 2022 -0.0894
April 30, 2022 0.00
January 31, 2022 0.0114
October 31, 2021 0.00
July 31, 2021 0.00
April 30, 2021 0.037
January 31, 2021 -0.0098
Date Value
October 31, 2020 -0.0142
July 31, 2020 -0.0062
April 30, 2020 -0.0134
January 31, 2020 -0.0194
October 31, 2019 -0.0001
July 31, 2019 0.0004
April 30, 2019 -0.0034
January 31, 2019 -0.0022
October 31, 2018 -0.0022
July 31, 2018 -0.0022
January 31, 2013 -0.0544
October 31, 2012 -0.60
July 31, 2012 -0.20
April 30, 2012 -1.60
January 31, 2012 -0.20
October 31, 2011 -0.0002
July 31, 2011 -0.0002
April 30, 2011 -0.0002
January 31, 2011 -0.0002
October 31, 2010 -0.0133
July 31, 2010 -0.0133

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. -0.4557
BioRestorative Therapies, Inc. -2.431
Astrana Health, Inc. 0.3965
CareDx, Inc. 2.071
Natera, Inc. -0.4674

EPS Diluted (Quarterly) Related Metrics